 Mildred Randolph
Concepts (102)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laboratory Animal Science | 2 | 2007 | 3 | 0.320 |
Why?
| | Animal Technicians | 1 | 2007 | 1 | 0.280 |
Why?
| | Noise, Occupational | 1 | 2007 | 3 | 0.280 |
Why?
| | Environmental Monitoring | 1 | 2007 | 67 | 0.270 |
Why?
| | Occupational Exposure | 1 | 2007 | 111 | 0.250 |
Why?
| | Occupational Medicine | 1 | 2005 | 4 | 0.250 |
Why?
| | Academies and Institutes | 1 | 2005 | 18 | 0.250 |
Why?
| | Occupational Health | 1 | 2005 | 66 | 0.240 |
Why?
| | Physicians | 1 | 2005 | 229 | 0.190 |
Why?
| | Laboratories | 1 | 2021 | 20 | 0.190 |
Why?
| | Motor Activity | 1 | 2021 | 222 | 0.170 |
Why?
| | Rodent Diseases | 2 | 2009 | 7 | 0.150 |
Why?
| | Cerebrovascular Circulation | 2 | 2004 | 128 | 0.100 |
Why?
| | Cocaine | 2 | 2004 | 172 | 0.100 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2004 | 185 | 0.090 |
Why?
| | Enterobius | 1 | 2009 | 3 | 0.080 |
Why?
| | Enterobiasis | 1 | 2009 | 3 | 0.080 |
Why?
| | Anal Canal | 1 | 2009 | 21 | 0.080 |
Why?
| | Diagnostic Tests, Routine | 1 | 2009 | 29 | 0.080 |
Why?
| | Animals | 9 | 2021 | 13141 | 0.080 |
Why?
| | Ear Protective Devices | 1 | 2007 | 2 | 0.070 |
Why?
| | Hearing Tests | 1 | 2007 | 23 | 0.070 |
Why?
| | Hearing Loss, Noise-Induced | 1 | 2007 | 9 | 0.070 |
Why?
| | Oxyuriasis | 1 | 2006 | 1 | 0.070 |
Why?
| | Oxyuroidea | 1 | 2006 | 1 | 0.070 |
Why?
| | Ivermectin | 1 | 2006 | 9 | 0.070 |
Why?
| | Antiparasitic Agents | 1 | 2006 | 10 | 0.070 |
Why?
| | Enterotoxins | 1 | 2006 | 12 | 0.070 |
Why?
| | Escherichia coli Infections | 1 | 2006 | 29 | 0.060 |
Why?
| | Mite Infestations | 1 | 2005 | 1 | 0.060 |
Why?
| | Mites | 1 | 2005 | 2 | 0.060 |
Why?
| | Permethrin | 1 | 2005 | 3 | 0.060 |
Why?
| | Bacterial Toxins | 1 | 2006 | 51 | 0.060 |
Why?
| | Insecticides | 1 | 2005 | 14 | 0.060 |
Why?
| | Escherichia coli Proteins | 1 | 2006 | 56 | 0.060 |
Why?
| | Housing, Animal | 2 | 2021 | 15 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 111 | 0.060 |
Why?
| | Risk Management | 1 | 2005 | 32 | 0.060 |
Why?
| | Escherichia coli | 1 | 2006 | 191 | 0.060 |
Why?
| | Mice, Transgenic | 1 | 2005 | 542 | 0.060 |
Why?
| | Mice | 5 | 2021 | 5673 | 0.060 |
Why?
| | Pia Mater | 1 | 2002 | 4 | 0.050 |
Why?
| | Sympatholytics | 1 | 2002 | 6 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2021 | 1195 | 0.050 |
Why?
| | Clonidine | 1 | 2002 | 25 | 0.050 |
Why?
| | Endothelin-1 | 1 | 2002 | 31 | 0.050 |
Why?
| | Adenoviridae | 1 | 2002 | 49 | 0.050 |
Why?
| | Vasoconstrictor Agents | 1 | 2002 | 83 | 0.050 |
Why?
| | Genetic Vectors | 1 | 2002 | 126 | 0.050 |
Why?
| | Serotonin | 1 | 2002 | 152 | 0.050 |
Why?
| | Prostate | 1 | 2002 | 117 | 0.050 |
Why?
| | Genetic Therapy | 1 | 2002 | 117 | 0.050 |
Why?
| | Locomotion | 1 | 2021 | 84 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2006 | 1419 | 0.040 |
Why?
| | Risk Assessment | 1 | 2005 | 1255 | 0.040 |
Why?
| | Temperature | 1 | 2021 | 165 | 0.040 |
Why?
| | Mutation | 1 | 2005 | 1288 | 0.040 |
Why?
| | Arterioles | 2 | 2004 | 33 | 0.030 |
Why?
| | Male | 5 | 2021 | 25572 | 0.030 |
Why?
| | Animals, Newborn | 2 | 2004 | 367 | 0.030 |
Why?
| | Swine | 2 | 2004 | 408 | 0.020 |
Why?
| | Rats | 2 | 2009 | 3277 | 0.020 |
Why?
| | Blood Pressure | 2 | 2004 | 527 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2009 | 160 | 0.020 |
Why?
| | Feces | 1 | 2009 | 131 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 871 | 0.020 |
Why?
| | Humans | 3 | 2007 | 50201 | 0.020 |
Why?
| | Administration, Topical | 1 | 2006 | 57 | 0.020 |
Why?
| | Mice, Inbred ICR | 1 | 2006 | 22 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2006 | 48 | 0.020 |
Why?
| | Colony Count, Microbial | 1 | 2006 | 66 | 0.020 |
Why?
| | Pregnancy | 2 | 2004 | 2609 | 0.020 |
Why?
| | Insect Control | 1 | 2005 | 2 | 0.020 |
Why?
| | Insect Bites and Stings | 1 | 2005 | 9 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 1581 | 0.020 |
Why?
| | Dermatitis | 1 | 2005 | 36 | 0.020 |
Why?
| | Research Personnel | 1 | 2005 | 65 | 0.020 |
Why?
| | Partial Pressure | 1 | 2004 | 14 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2004 | 177 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2004 | 92 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2004 | 94 | 0.010 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2004 | 131 | 0.010 |
Why?
| | Vasoconstriction | 1 | 2002 | 55 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 2002 | 35 | 0.010 |
Why?
| | Birth Weight | 1 | 2002 | 121 | 0.010 |
Why?
| | Sputum | 1 | 2002 | 65 | 0.010 |
Why?
| | Autonomic Nervous System | 1 | 2002 | 57 | 0.010 |
Why?
| | Vasodilation | 1 | 2002 | 98 | 0.010 |
Why?
| | Rectum | 1 | 2002 | 52 | 0.010 |
Why?
| | Dogs | 1 | 2002 | 185 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2002 | 166 | 0.010 |
Why?
| | DNA Primers | 1 | 2002 | 207 | 0.010 |
Why?
| | Oxygen | 1 | 2004 | 321 | 0.010 |
Why?
| | Heart Rate | 1 | 2002 | 301 | 0.010 |
Why?
| | Fetus | 1 | 2002 | 218 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2002 | 456 | 0.010 |
Why?
| | Female | 3 | 2006 | 26829 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2002 | 1356 | 0.010 |
Why?
| | Models, Biological | 1 | 2002 | 722 | 0.010 |
Why?
| | DNA | 1 | 2002 | 543 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 2002 | 393 | 0.010 |
Why?
| | Child, Preschool | 1 | 2006 | 3896 | 0.010 |
Why?
|
|
Randolph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|